LACY THOMAS: Open Payments
NPI 1427615087 · SAINT FRANCISVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 47 payments from 10 companies in 2025. Trend: 2023 $574 · 2024 $803 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $198 |
| ABBVIE INC. | 18 | $149 |
| GlaxoSmithKline, LLC. | 7 | $124 |
| Phathom Pharmaceuticals, Inc. | 6 | $67 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, Wegovy, TRELEGY ELLIPTA, VOQUEZNA, ELIQUIS, Ozempic, ZEPBOUND, Rybelsus.
Industry payments across LA — which companies pay providers there.
